From 2019, every new car that Volvo launches is set to be electrified. The business wants fully-electric cars to account for 50 percent of overall global sales by the year 2025.
“To support wider consumer adoption of electric cars, society needs to make charging an electric car as simple as filling up your tank,” Zaki Fasihuddin, the Volvo Cars Tech Fund CEO, said in a statement. “Our investment in FreeWire is a firm endorsement of the company’s ambitions in this area.”
In 2017, there were more than 3 million electric and plug-in hybrid cars on the planet’s roads, according to the International Energy Agency’s (IEA) Global Electric Vehicles Outlook. This represents an increase of 54 percent compared to 2016.
Almost 580,000 electric cars were sold in China last year, according to the IEA, while around 280,000 were sold in the U.S.
In terms of charging infrastructure, the IEA says that, globally, there were an estimated 3 million private chargers at homes and workplaces in 2017. The number of “publicly accessible” chargers amounted to roughly 430,000.
Image: REUTERS/Nick Carey
Graphene is a modern marvel. It is comprised of a single, two-dimensional layer of carbon, yet is 200 times stronger than steel and more conductive than any other material, according to the University of Manchester, where it was first isolated in 2004.
Graphene also has multiple potential uses, including in biomedical applications such as targeted drug delivery, and for improving the lifespan of smartphone batteries.
Now, a team of researchers at the University of Arkansas has found evidence to suggest graphene could also be used to provide an unlimited supply of clean energy.
The team says its research is based on graphene’s ability to “ripple” into the third dimension, similar to waves moving across the surface of the ocean. This motion, the researchers say, can be harvested into energy.
To study the movement of graphene, lead researcher Paul Thibado and his team laid sheets of the material across a copper grid that acted as a scaffold, which allowed the graphene to move freely.
Thibado says graphene could power biomedical devices such as pacemakers.
Image: Russell Cothren
The researchers used a scanning tunnelling microscope (STM) to observe the movements, finding that narrowing the focus to study individual ripples drew clearer results.
In analysing the data, Thibado observed both small, random fluctuations, known as Brownian motion, and larger, coordinated movements.
A scanning tunnelling microscope.
Image: University of Arkansas
As the atoms on a sheet of graphene vibrate in response to the ambient temperature, these movements invert their curvature, which creates energy, the researchers say.
“This is the key to using the motion of 2D materials as a source of harvestable energy,” Thibado says.
“Unlike atoms in a liquid, which move in random directions, atoms connected in a sheet of graphene move together. This means their energy can be collected using existing nanotechnology.”
The pieces of graphene in Thibado’s laboratory measure about 10 microns across (more than 20,000 could fit on the head of a pin). Each fluctuation exhibited by an individual ripple measures only 10 nanometres by 10 nanometres, and could produce 10 picowatts of power, the researchers say.
As a result, each micro-sized membrane has the potential to produce enough energy to power a wristwatch, and would never wear out or need charging.
Sheet of graphene as seen through Thibado’s STM
Image: University of Arkansas
Thibado has created a device, called the Vibration Energy Harvester, that he claims is capable of turning this harvested energy into electricity, as the below video illustrates.
This self-charging power source also has the potential to convert everyday objects into smart devices, as well as powering more sophisticated biomedical devices such as pacemakers, hearing aids and wearable sensors.
Thibado says: “Self-powering enables smart bio-implants, which would profoundly impact society.”
Have you read?
A new cancer therapy using nanoparticles to deliver a combination therapy direct to cancer cells could be on the horizon, thanks to research from the University of East Anglia.
And scientists at UEA’s Norwich Medical School have confirmed that it can be mass-produced, making it a viable treatment if proved effective in human trials.
Using nanoparticles to get drugs directly into a tumour is a growing area of cancer research. The technology developed at UEA is the first of its kind to use nanoparticles to deliver two drugs in combination to target cancer cells.
The drugs, already approved for clinical use, are an anti-cancer drug called docetaxel, and fingolimod, a multiple sclerosis drug that makes tumours more sensitive to chemotherapy.
Fingolimod cannot currently be used in cancer treatment because it also supresses the immune system, leaving patients with dangerously low levels of white blood cells.
And while docetaxel is used to treat many cancers, particularly breast, prostate, stomach, head and neck and some lung cancers, its toxicity can also lead to serious side effects for patients whose tumours are chemo-resistant.
Because the nanoparticles developed by the UEA team can deliver the drugs directly to the tumour site, these risks are vastly reduced. In addition, the targeted approach means less of the drug is needed to kill off the cancer cells.
“So far nobody has been able to find an effective way of using fingolimod in cancer patients because it’s so toxic in the blood,” explains lead researcher, Dr. Dmitry Pshezhetskiy from the Norwich Medical School at UEA.
“We’ve found a way to use it that solves the toxicity problem, enabling these two drugs to be used in a highly targeted and powerful combination.”
The UEA researchers worked with Precision NanoSystems’ Formulation Solutions Team who used their NanoAssemblr technology to investigate if it was possible to synthesise the different components of the therapy at an industrial scale.
Following successful results on industrial scale production, and a published international patent application, the UEA team is now looking for industrial partners and licensees to move the research towards a phase one clinical trial.
Also included within the nanoparticle package are molecules that will show up on an MRI scan, enabling clinicians to monitor the spread of the particles through the body.
The team has already carried out trials in mice that show the therapy is effective in reducing breast and prostate tumours. These results were published in 2017.
“Significantly, all the components used in the therapy are already cleared for clinical use in Europe and the United States,” says Dr. Pshezhetskiy. “This paves the way for the next stage of the research, where we’ll be preparing the therapy for patient trials.”
“New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth,” by Heba Alshaker, Qi Wang, Shyam Srivats, Yimin Chao, Colin Cooper and Dmitri Pchejetski was published in Breast Cancer Research and Treatment on 10 July 2017.
“Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer,” by Qi Wang, Heba Alshaker, Torsten Böhler, Shyam Srivats, Yimin Chao, Colin Cooper and Dmitri Pchejetski was published in Scientific Reports on 19 July 2017.
Explore further: Lipid molecules can be used for cancer growth
More information: Heba Alshaker et al. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth, Breast Cancer Research and Treatment (2017). DOI: 10.1007/s10549-017-4380-8
Qi Wang et al. Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer, Scientific Reports (2017). DOI: 10.1038/s41598-017-06142-x
25 Aug 2018
Northeast Atlantic bathymetry, with Porcupine Bank and the Porcupine Seabight labelled.
A research expedition to a huge underwater canyon off the Irish coast has shed light on a hidden process that sucks the greenhouse gas carbon dioxide (CO2) out of the atmosphere.
Researchers led by a team from the University College Cork (UCC) took an underwater research drone by boat out to Porcupine Bank Canyon — a massive, cliff-walled underwater trench where Ireland’s continental shelf ends — to build a detailed map of its boundaries and interior. Along the way, the researchers reported in a statement, they noted a process at the edge of the canyon that pulls CO2 from the atmosphere and buries it deep under the sea.
All around the rim of the canyon live cold-water corals, which thrive on dead plankton raining down from the ocean surface. Those tiny, surface-dwelling plankton build their bodies out of carbon extracted from CO2 in the air. Then, when they die, the coral on the seafloor consume them and build their bodies out of the same carbon. Over time, as the coral die and the cliff faces shift and crumble, which sends the coral falling deep into the canyon. There, the carbon pretty much stays put for long periods. [ In Photos: ROV Explores Deep-Sea Marianas Trench
There’s evidence that a lot of carbon is moving this way; the researchers said they found “significant” dead coral buildup at the canyon bottom.
This process doesn’t move nearly enough carbon dioxide to prevent climate change, the researchers said. But it does shed light on yet another mechanism that keeps the planet’s CO2 levels regulated when human industry doesn’t interfere.
“Increasing CO2 concentrations in our atmosphere are causing our extreme weather,” Andy Wheeler, a UCC geoscientist and one of the researchers on the expedition, said in the statement. “Oceans absorb this CO2 and canyons are a rapid route for pumping it into the deep ocean where it is safely stored away.”
The mapping expedition covered an area about the size of Chicago and revealed places where the canyon has moved and shifted significantly in the past.
“We took cores with the ROV, and the sediments reveal that although the canyon is quiet now, periodically it is a violent place where the seabed gets ripped up and eroded,” Wheeler said.
The expedition will return to shore today (Aug. 10).
One of the biggest challenges to the recovery of someone who has experienced a major physical trauma such as a heart attack is the growth of scar tissue.
As scar tissue builds up in the heart, it can limit the organ’s functions, which is obviously a problem for recovery.
However, researchers from the Science Foundation Ireland-funded Advanced Materials and BioEngineering Research (AMBER) Centre have revealed a new biomaterial that actually ‘grows’ healthy tissue – not only for the heart, but also for people with extensive nerve damage.
In a paper published to Advanced Materials, the team said its biomaterial regenerating tissue responds to electrical stimuli and also eliminates infection.
The new material developed by the multidisciplinary research team is composed of the protein collagen, abundant in the human body, and the atom-thick ‘wonder material’ graphene.
The resulting merger creates an electroconductive ‘biohybrid’, combining the beneficial properties of both materials and creating a material that is mechanically stronger, with increased electrical conductivity.
This biohybrid material has been shown to enhance cell growth and, when electrical stimulation is applied, directs cardiac cells to respond and align in the direction of the electrical impulse.
Could repair spinal cord
It is able to prevent infection in the affected area because the surface roughness of the material – thanks to graphene – results in bacterial walls being burst, simultaneously allowing the heart cells to multiply and grow.
For those with extensive nerve damage, current repairs are limited to a region only 2cm across, but this new biomaterial could be used across an entire affected area as it may be possible to transmit electrical signals across damaged tissue.
Speaking of the breakthrough, Prof Fergal O’Brien, deputy director and lead investigator on the project, said: “We are very excited by the potential of this material for cardiac applications, but the capacity of the material to deliver physiological electrical stimuli while limiting infection suggests it might have potential in a number of other indications, such as repairing damaged peripheral nerves or perhaps even spinal cord.
“The technology also has potential applications where external devices such as biosensors and devices might interface with the body.”
The study was led by AMBER researchers at the Royal College of Surgeons in Ireland in partnership with Trinity College Dublin and Eberhard Karls University in Germany.
IMAGE: SAMPLES OF NANOHYBRIDS OBTAINED IN NUST MISIS “INORGANIC NANOMATERIALS ” LABORATORY view more CREDIT: ©NUST MISIS
NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY MISIS
Scientists from the National University of Science and Technology MISIS (NUST MISIS), the State Research Center for Applied Microbiology and Biotechnology and the Queensland University (Brisbane, Australia) have created BN/Ag hybrid nanomaterials and have proved their effectiveness as catalysts and antibacterial agents as well as for treating oncological diseases. The results are published in the Beilstein Journal of Nanotechnology.
The interest in the nanomaterials is related to the fact that when a particle is decreased to nanometers (1 nanometer = 10-9 meter) its electronic structure changes, and the material acquires new physical and chemical properties. For example, a magneto can lose its magnetism completely when decreased to ten nanometers.
Today, scientists are beginning to study combinations of various materials at the nanolevel instead of as separate nanoparticles (fullerenes and nanotubes). They have come up with a concept of hybrid nanomaterials, which combine the properties of individual components.
Hybridization makes it possible to combine properties that were incompatible before, for example, to create a material that can be a solid and a plastic at the same time. In addition, the scientists noted that combinations of nanomaterials often showed better or even new properties. Today the nanohybrid area is only beginning to develop.
MISIS scientists are studying the properties of BN hybrid nanomaterials. BN (boron nitride) was chosen as the base for new hybrid nanoparticles because it is chemically inert and biocompatible and has low relative density.
BN hybrid nanomaterials are used as prospective key components of the next generation advanced biomaterials, catalysts and sensors. These hybrids have advantageous combination of properties, such as biocompatibility, high tensile strength and thermal conductivity as well as superb chemical stability and electrical insulation. This explains their rich functionality for developing new biomedicines, reinforcement of ultralight metals and polymers and production of transparent superhydrophobic films and quantum devices.
“We have studied BN/Ag nanohybrid properties and have discovered a high potential for new applications. We were especially interested in an application for treating oncological diseases as well as their activity as catalysts and antibacterial agents,” said Andrei Matveyev, a research author, Senior Research Fellow at the MISIS Inorganic Materials Laboratory.
According to Matveyev, these nanohybrids can be used in cancer therapy as a base for drug delivery medicines. The nanohybrids with the drug become containers to be delivered inside cancer cells. Nanohybrids are chemically modified by attaching folic acid (vitamin ?9) to its surface through an Ag nanoparticle.
The modified nanohybrids with folic acid are mostly accumulated in cancer cells, because they have an increased number of folic acid receptors, so the concentration grows thousand times higher than in healthy cells. In addition, the acidity in a cancer cell is also higher than in the intercellular space, which leads to the drug’s release from its nanocontainer.
“This is why the drug is mostly released inside cancer cells, which decreases the general concentration of the drug in the organism, thus preventing toxicity,” Matveyev notes.
The authors believe that nanohybrids modified for drug delivery can be applied to uses in isotope and neuron capture cancer therapy.
The synthesized particles have also demonstrated high antibacterial activity against test bacteria: Escherichia coli live in dirty water, so water disinfection by nanohybrids may prove useful in emergencies or during war time.
Nanohybrids based on BN/Ag nanoparticles can also be used as an ultraviolet photoactive material.
21 Feb 2018
University of Texas at Austin. This is the world’s thinnest wearable Health Monitor, designed and developed by the researchers at the University of Texas at Austin, in the form of a “Graphene-Ink Tattoo”.
Most health monitors in use today are bulky and tend to restrict patients movements. This graphene tattoo will eliminate these restrictions. It picks up electric signal given off by the body and transmits it to a smartphone app.
Rice University scientists who introduced laser-induced graphene (LIG) have enhanced their technique to produce what may become a new class of edible electronics.
The Rice lab of chemist James Tour, which once turned Girl Scout cookies into graphene, is investigating ways to write graphene patterns onto food and other materials to quickly embed conductive identification tags and sensors into the products themselves.
“This is not ink,” Tour said. “This is taking the material itself and converting it into graphene.” Read More: Rice University Expands LIG (laser induced graphene) Research
Automated, unmanned drones are poised to revolutionize the package delivery industry, with a number of companies already testing drone-based delivery methods.
A new study in Nature Communications looks at the climate impact of a shift from truck-based to drone-based package delivery. It finds that while small drones carrying packages weighing less than 0.5 kg would reduce greenhouse gas emissions compared to diesel or electric trucks anywhere in the U.S., the same is not true for larger drones carrying heavier packages.
Watch Our New Tenka Energy Video:
Tenka Energy, Inc. Building Ultra-Thin Energy Dense SuperCaps and NexGen Nano-Enabled Pouch & Cylindrical Batteries – Energy Storage Made Small and POWERFUL! YouTube Video
Despite being a promising electrode material, bulk cobalt oxide (Co3O4) exhibits poor lithium ion storage properties. Nanostructuring, e.g. making Co3O4 into ultrathin nanosheets, shows improved performance, however, Co3O4-based nanomaterials still lack long-term stability and high rate capability due to sluggish ion transport and structure degradation. Read More …
MIT: Device makes power conversion more efficient New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid
Power electronics, which do things like modify voltages or convert between direct and alternating current, are everywhere. They’re in the power bricks we use to charge our portable devices; they’re in the battery packs of electric cars; and they’re in the power grid itself, where they mediate between high-voltage transmission lines and the lower voltages of household electrical sockets. Read More …
Elon Musk and Tesla have made some bold claims for the new Tesla Semi and Roadster. Those who understand batteries have been scratching their heads trying to figure out how the company can deliver the specs it’s promising – and concluding that the only possible way is some as-yet-unannounced advancement in battery technology. Read More …
Watch Our Video on New Energy Storage Technology: Supercapacitors and Batteries
20 Jul 2017
Genesis Nanotechnology, Inc.
“Great Things from Small Things” ~ GNT™
Read this edition of Genesis Nanotechnology Online featuring: